Home » Newsletters » BioWorld

BioWorld

April 15, 1993

View Archived Issues

DNAP EXPANDS TEST MARKETS FOR ITS VINESWEET TOMATO

EDITEK'S ONE-STEP ASSAY RECEIVES PATENT

IMCLONE GETS LICENSE TO EGFR MABS

SANDOZ SELLS HUMAN MAbs TO PDL FOR $5 MILLION

SANDOZ AND SYSTEMIX TEAM UP FOR AIDS GENE THERAPY

CALGENE WILL LABEL ITS ANTISENSE TOMATO

GREENWICH FILES PLA

LIFECELL GETS SBIR GRANT

CELLTECH TO BUILD MANUFACTURING FACILITY IN N.H.

PPTI GETS PATENT FOR BETASILK

SANDOZ LICENSES BTG'S AMINOPEPTIDASE

ARMY TRANSFERS AIDS TRIAL FUNDS TO DHHS

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...